A phase II trial to determine the cosmetic outcomes and toxicity of 27  Gy in five-fraction accelerated partial breast irradiation: the ACCEL trial

ConclusionsThis trial will assess the cosmetic and normal tissue outcomes of external beam APBI delivered in 1  week for early-stage breast cancer.Trial registrationRegistration number: NCT02681107 (clinicaltrials.gov), registered February 2, 2016.
Source: Journal of Radiation Oncology - Category: Cancer & Oncology Source Type: research